NCT01650064

Completed

Latin America Hip Fracture Mortality Study

AO Clinical Investigation and Publishing Documentation Source

Compare

Other study identifiers

Sponsor study identifier

LAMOS

Study Type

observational

Actual enrollment (reported)

168

Locations

8 countries

Sites

16

Timeline

Study Start

January 2013

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

April 2016

Actual (reported)

Study Completion

December 2016

Actual (reported)

Brief Summary

The purpose of this study is to estimate the survival proportion one year after surgery for intertrochanteric fracture in older adults in Latin America.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 168 participants
Study completion date: December 2016
Actual (reported)
Listed locations: 8 countries · 16 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
July 6, 2012
Actual (reported)
First Posted
July 26, 2012
Actual (reported)
Study Start
January 2013
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
April 2016
Actual (reported)
Study Completion
December 2016
Actual (reported)

Last Updated: August 13, 2020
Status Verified: January 2017
Last Update Submitted: August 11, 2020

Conditions

Hip Fractures

Keywords

Hip fractureMortality

Outcome Measures

Primary Outcomes (1)

Death
after 1 year

Secondary Outcomes (6)

Harris Hip Score
Screening/Preoperative and 90 ± 21 days
Parker Mobility Score
Screening/Preoperative, 30±7 days, 60±14 days, 90± 21 days, 365 (up to 425) days
Wound healing
30±7 days, 60±14 days, and 90± 21 days
Fracture healing
60±14 days and 90± 21 days
Anticipated surgical treatment-related adverse events
Postoperative (2 to 5 days), 30±7 days, 60±14 days, 90±21 days, 180±121 days, and 365 (up to 425) days
+1 more secondary outcomes

Eligibility Criteria

Age60 Years - 110 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients with surgically-treated hip fracture in Latin America

You may qualify if:

Adults 60 years and older

Sponsors & Collaborators

AO Clinical Investigation and Publishing Documentation
Otherlead

Study Sites (16)

Hospital Italiano de Buenos Aires

Buenos Aires, Argentina

Hospital Vila Velha

Espírito Santo, Brazil

IOT - Instituto de Ortopedia de Traumatologia de Passo Fundo

Passo Fundo, Brazil

Hospital Municipal Miguel Couto

Rio de Janeiro, Brazil

Hospital das Clinicas da UNICAMP

São Paulo, Brazil

Hospital Irmandade da Santa Casa de Misericórdia de São Paulo

São Paulo, Brazil

Hospital São Paulo

São Paulo, Brazil

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

Wiliam Belangero, Dr.med
Department of Orthopaedics and Traumatology, Hospital das Clinicas da UNICAMP, Brazil
PRINCIPAL INVESTIGATOR

Enrollment

168 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

July 6, 2012

First Posted

July 26, 2012

Study Start

January 2013

Date type not reported

This date has not been verified as actual or estimated.

NCT02998359

Hemiarthroplasty Versus Total Hip Replacement for Intracapsular Hip Fractures

Not ApplicableCompleted

NCT02450045

Pre-op Femoral Nerve Block for Hip Fracture

Not ApplicableTerminated

NCT01593319

Is Regional Anesthesia of the Hip Preferable Over Traditional Analgesia in the Acute Stage of the Management of Patients With a Fracture of the Hip

Phase 4Terminated

NCT01984385

Hip Fracture Impact on Vascular Events In Noncardiac Surgery patIents: a cOhort evaluatioN (Hip VISION): Pilot Study

Completed

NCT01850251

Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Muscle Strength in Hip Fracture

Phase 4Terminated

NCT02564133

Hip Fracture and Patent Foramen Ovale

Not ApplicableTerminated

Diagnosis of an isolated intertrochanteric fracture (AO 31-A) confirmed by radiographic evaluation

Primary surgical fracture treatment within 10 days after trauma

No prior treatment for the fracture

Ability to understand the content of the patient information / informed consent form

Willingness and ability to participate in the clinical investigation according to the CIP

Signed and dated IRB/EC-approved written informed consent

You may not qualify if:

Polytrauma (ie, multiple injuries, whereof one or the combination of several injuries is life threatening)
Pathologic fracture due to a disease other than osteoporosis (eg, tumor, metastasis)
Active malignancy
Class 5 and 6 of the American Society of Anesthesiologists (ASA) physical status classification (Appendix 2)
Neurological and/or psychiatric disorders that would preclude reliable assessment (eg, Parkinson's disease, multiple sclerosis, severe depression)
Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment
Prisoner
Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Noncompletion of patient baseline questionnaires
Prior implant on the fractured hip

Contact the study team to confirm eligibility.

Universidad de São Paulo

São Paulo, Brazil

Hospital Clínico Pontificia Universidad Católica de Chile

Santiago, Chile

Hospital del Trabajador de Santiago

Santiago, Chile

Hospital Infantil de San José

Bogotá, Colombia

Hospital San Vicente de Paúl

San José, Costa Rica

Hospital Teodoro Maldonado Carbo

Guayaquil, Ecuador

Hospital de Traumatología y Ortopedia "Lomas Verdes"

Mexico City, Mexico

Hospital de Traumatología y Ortopedia UMAE #21

Monterrey, Mexico

Asociación Española Primera de Socorros Mutuos

Montevideo, Uruguay

Primary Completion

April 2016

Actual (reported)

Study Completion

December 2016

Actual (reported)

Last Updated

August 13, 2020

Record last verified: 2017-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01650064
Data provider: ClinicalTrials.gov
Source updated: 2020-08-13
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:35:43 UTC

Locations

AR(1)BR(7)CL(2)CO(1)CR(1)EC(1)MX(2)UY(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (6)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (16)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations